A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
Hi,
Hi,
I recommend starting with clarifying the objective - Which metrics you need to achieve with the product? Most probably it will be ROI.
I would also clarify whether it's our painkiller on the market or the product of the competitors since competition and cannibalization are the two different cases. Then I will follow up with the structure:
Analyze our product:
Analyze the market:
Analyze the competitors:
investment decision:
Best!
(edited)
Hi Anonymous,
the new drug should be launched if the net value associated with this move exceeds the investment cost over the client's target investment horizon. Morover, Risk needs to be manageable.
So you have 4 buckets to investigate:
Cheers, Sidi